Page last updated: 2024-09-04

tipifarnib and pevonedistat

tipifarnib has been researched along with pevonedistat in 1 studies

Compound Research Comparison

Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010)
(tipifarnib)
Studies
(pevonedistat)
Trials
(pevonedistat)
Recent Studies (post-2010) (pevonedistat)
309929429911289

Protein Interaction Comparison

ProteinTaxonomytipifarnib (IC50)pevonedistat (IC50)
Ubiquitin-like modifier-activating enzyme 6Homo sapiens (human)1.8
Ubiquitin-like modifier-activating enzyme 1 Mus musculus (house mouse)1.5
NEDD8-activating enzyme E1 regulatory subunitHomo sapiens (human)0.0471
NEDD8Homo sapiens (human)0.0047
NEDD8-activating enzyme E1 catalytic subunitHomo sapiens (human)0.0033
SUMO-activating enzyme subunit 1Homo sapiens (human)8.2
SUMO-activating enzyme subunit 2Homo sapiens (human)8.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buuh, ZY; Lyu, Z; Wang, RE1

Reviews

1 review(s) available for tipifarnib and pevonedistat

ArticleYear
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.
    Journal of medicinal chemistry, 2018, 04-26, Volume: 61, Issue:8

    Topics: Acetylation; Animals; Citrullination; Enzyme Inhibitors; Glycosylation; Humans; Methylation; Phosphorylation; Protein Prenylation; Protein Processing, Post-Translational; Proteins; Ubiquitination

2018